Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
Study Confirms Anti-Infective ARIKACE(TM) Effectively Penetrates Mucus and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic Fibrosis Patients
CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
Mercury Therapeutics Patents Filed
Biography of Courage and Medical Innovation Top Choice of Readers, Editors and Publishers
Synosia Starts Phase II Efficacy Trial For Rufinamide
Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
Biotage Launches New 24 Well Pyrosequencing(R) System
Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
Tryton Medical, Inc. Closes $14 Million Financing
Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2008 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.